JP2021525704A5 - - Google Patents

Info

Publication number
JP2021525704A5
JP2021525704A5 JP2020563751A JP2020563751A JP2021525704A5 JP 2021525704 A5 JP2021525704 A5 JP 2021525704A5 JP 2020563751 A JP2020563751 A JP 2020563751A JP 2020563751 A JP2020563751 A JP 2020563751A JP 2021525704 A5 JP2021525704 A5 JP 2021525704A5
Authority
JP
Japan
Prior art keywords
compound
composition according
approximately
plasma concentration
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020563751A
Other languages
English (en)
Japanese (ja)
Other versions
JP7519909B2 (ja
JP2021525704A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/033727 external-priority patent/WO2019222764A1/en
Publication of JP2021525704A publication Critical patent/JP2021525704A/ja
Publication of JP2021525704A5 publication Critical patent/JP2021525704A5/ja
Priority to JP2024109855A priority Critical patent/JP2025011059A/ja
Application granted granted Critical
Publication of JP7519909B2 publication Critical patent/JP7519909B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020563751A 2018-05-16 2019-05-23 Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス Active JP7519909B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024109855A JP2025011059A (ja) 2018-05-16 2024-07-08 Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862672384P 2018-05-16 2018-05-16
PCT/US2019/033727 WO2019222764A1 (en) 2018-05-16 2019-05-23 Compositions comprising pgi2-receptor agonists and processes for the preparation thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024109855A Division JP2025011059A (ja) 2018-05-16 2024-07-08 Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス

Publications (3)

Publication Number Publication Date
JP2021525704A JP2021525704A (ja) 2021-09-27
JP2021525704A5 true JP2021525704A5 (https=) 2022-05-27
JP7519909B2 JP7519909B2 (ja) 2024-07-22

Family

ID=67660444

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020563751A Active JP7519909B2 (ja) 2018-05-16 2019-05-23 Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス
JP2024109855A Pending JP2025011059A (ja) 2018-05-16 2024-07-08 Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024109855A Pending JP2025011059A (ja) 2018-05-16 2024-07-08 Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス

Country Status (5)

Country Link
US (2) US12433865B2 (https=)
EP (1) EP3796902A1 (https=)
JP (2) JP7519909B2 (https=)
KR (1) KR20210040837A (https=)
WO (1) WO2019222764A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL268997B2 (en) 2017-03-01 2023-09-01 Arena Pharm Inc Preparations containing pgi2 receptor agonists and processes for their preparation
WO2023158634A1 (en) 2022-02-15 2023-08-24 United Therapeutics Corporation Crystalline prostacyclin (ip) receptor agonist and uses thereof

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945530A1 (de) 1979-11-10 1981-06-04 Chemische Werke Hüls AG, 4370 Marl Harnstoffe mit cyclischen substituenten, ihre herstellung und verwendung als herbizide
JPH03160438A (ja) 1989-11-20 1991-07-10 Konica Corp ハロゲン化銀カラー写真感光材料
EP0442448A3 (en) 1990-02-13 1992-08-12 Bristol-Myers Squibb Company Heterocyclic carboxylic acids and esters
CA2085844A1 (en) 1991-12-27 1993-06-28 Nobuyuki Hamanaka Fused benzeneoxyacetic acid derivatives
JPH06329598A (ja) 1993-05-19 1994-11-29 Daicel Chem Ind Ltd エステルの製造方法
GT199800126A (es) 1997-08-29 2000-01-29 Terapia de combinacion.
JPH11269138A (ja) 1998-03-20 1999-10-05 Mitsubishi Paper Mills Ltd 有機塩基発生剤
GB9908934D0 (en) 1999-04-19 1999-06-16 Rolic Ag Liquid crystalline compounds
EP1046631A1 (en) 1999-04-19 2000-10-25 Rolic AG Liquid crystalline compounds
US20040048844A1 (en) 1999-10-20 2004-03-11 Bristol-Myers Squibb Pharma Company Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
WO2002055484A1 (en) 2001-01-12 2002-07-18 Takeda Chemical Industries, Ltd. Biaryl compound, process for producing the same, and agent
WO2003007888A2 (en) 2001-07-20 2003-01-30 Adipogenix, Inc. Fat accumulation-modulating compounds
CN101284773A (zh) 2001-08-09 2008-10-15 小野药品工业株式会社 羧酸衍生物及以它为活性成分的药剂
TW200307539A (en) 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
US7086532B2 (en) 2003-07-16 2006-08-08 Allergan, Inc. Titration/compliance pack with increasing doses
TWI293715B (en) 2002-10-10 2008-02-21 Sipix Imaging Inc A method for inducing or enhancing the threshold of an electrophoretic display, an electrophoretic fluid and an electrophoretic display
RU2351590C2 (ru) 2003-02-10 2009-04-10 Вертекс Фармасьютикалз Инкорпорейтед Способ получения диариламина
JP4402413B2 (ja) 2003-09-29 2010-01-20 財団法人２１あおもり産業総合支援センター Ｕ字型化合物およびこれを含む液晶組成物
DE102004006785A1 (de) 2004-02-11 2005-09-08 Mayr, Herbert, Prof. Dr. Verfahren zur CC-Bindungsknüpfung zwischen elektrophilen Substraten und TT-Verbindungen in neutralen bis basischen wässrigen oder alkoholischen Lösungsmitteln ohne den Einsatz einer Lewis- oder Protonensäure
JP2008510726A (ja) 2004-08-20 2008-04-10 エントレメッド インコーポレイテッド プロテイナーゼ活性化受容体アンタゴニストを含む組成物および方法
JP2006083085A (ja) 2004-09-15 2006-03-30 Kyowa Hakko Kogyo Co Ltd 二環性ピリミジン誘導体の製造法およびその合成中間体
JP4792731B2 (ja) 2004-11-12 2011-10-12 Ｄｉｃ株式会社 重合性液晶組成物及び当該組成物の硬化物
WO2007051255A1 (en) 2005-11-04 2007-05-10 The University Of Sydney Process for the preparation of compounds containing an azacyclic ring system
JP2007161867A (ja) 2005-12-14 2007-06-28 Toyo Ink Mfg Co Ltd インキ組成物
US20080075692A1 (en) 2006-05-09 2008-03-27 Perrine Susan P Methods for treating blood disorders
EP2548552B1 (en) 2007-09-12 2015-11-18 Merz Pharma GmbH & Co. KGaA Titration package for 1-amino-alkylcyclohexanes
WO2009117095A1 (en) 2008-03-18 2009-09-24 Arena Pharmaceuticals, Inc. Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
US20110224262A1 (en) 2008-11-26 2011-09-15 Arena Pharmaceuticals, Inc. Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
ES2548882T3 (es) 2008-12-08 2015-10-21 Arena Pharmaceuticals, Inc. Moduladores del receptor de prostaciclina (PGl2) útiles para el tratamiento de trastornos relacionados con los mismos
WO2011037613A1 (en) 2009-09-23 2011-03-31 Arena Pharmaceuticals, Inc. Crystalline forms and processes for the preparation of pgi2 receptor agonists
US10537546B2 (en) 2014-10-23 2020-01-21 Arena Pharmaceuticals, Inc. Method of treating conditions related to the PGI2 receptor
US12377067B2 (en) * 2016-11-10 2025-08-05 Arena Pharmaceuticals, Inc. Methods of treating PAH with combinations of ralinepag and other agents
IL268997B2 (en) 2017-03-01 2023-09-01 Arena Pharm Inc Preparations containing pgi2 receptor agonists and processes for their preparation

Similar Documents

Publication Publication Date Title
CN103402519B (zh) 肿瘤治疗剂
US6544556B1 (en) Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
US20100221336A1 (en) Method of treating arthritis, pain or inflammation with naproxen 2(methanesulfonyl)ethyl ester and a proton pump inhibitor
JP2020510660A5 (https=)
CN114072396A (zh) 作为dna-pk抑制剂的喹啉和噌啉衍生物
RU2011150228A (ru) Системы пленочного покрытия для препаратов с немедленным высвобождением, создающие усиленный барьер от влаги, и субстраты с таким покрытием
EP2205279B1 (en) Pharmaceutical combination of aliskiren and valsartan
JP2016534153A5 (https=)
JP2015510916A5 (https=)
JP2015524472A5 (https=)
SI2760821T1 (en) A salt salt of an anti-inflammatory substituted cyclobutenedione compound
JP2021525704A5 (https=)
RU2015138443A (ru) Способы лечения ангионевротического отека, опосредованного рецепторами брадикинина в2
JP2023530316A5 (https=)
JP2022119852A5 (https=)
JP2016514141A5 (https=)
MX2022009032A (es) Metodo de tratamiento de afecciones relacionadas con el receptor pgi2.
JP2022511788A5 (https=)
JP2023528014A5 (https=)
CA2991156A1 (en) Compositions and methods for the treatment of viral infection
CR20210043A (es) Forma de dosificación farmacèutica administrable por vía oral con liberación modificada
CN101801355A (zh) 包含一种或多种hmg-coa还原酶抑制剂的稳定药物组合物
EP3157520B1 (en) Apremilast for the treatment of a liver disease or a liver function abnormality
JP2013544794A5 (https=)
WO2017155053A1 (ja) 非アルコール性脂肪性肝疾患／非アルコール性脂肪性肝炎の治療剤